Literature DB >> 6538092

Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy.

B Perrot, N Danchin, A Terrier de la Chaise.   

Abstract

Sudden death was recorded by continuous ambulatory electrocardiographic (Holter) monitoring in a 62 year old man with hypertrophic cardiomyopathy and atrial fibrillation, who had been treated for four days with verapamil 360 mg orally. Analysis of the tape showed a third degree atrioventricular block followed by complete asystole. The sudden death could be related to treatment with verapamil.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6538092      PMCID： PMC481511          DOI： 10.1136/hrt.51.3.352

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  10 in total

1.  Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation.

Authors:  J B Schwartz; D Keefe; R E Kates; E Kirsten; D C Harrison
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

2.  [Acute treatment with verapamil of paroxysmal supraventricular tachycardia and atrial flutter in paediatric age (author's transl)].

Authors:  B Musto; R Greco; R Calabrò; F Marsico
Journal:  G Ital Cardiol       Date:  1979

3.  Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.

Authors:  S E Epstein; D R Rosing
Journal:  Circulation       Date:  1981-09       Impact factor: 29.690

4.  Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.

Authors:  W J McKenna; D England; Y L Doi; J E Deanfield; C Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1981-08

5.  Three cases of severe verapamil poisoning.

Authors:  P Immonen; A Linkola; E Waris
Journal:  Int J Cardiol       Date:  1981       Impact factor: 4.164

6.  Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil.

Authors:  R O Bonow; T M Frederick; S L Bacharach; M V Green; P W Goose; B J Maron; D R Rosing
Journal:  Am J Cardiol       Date:  1983-05-01       Impact factor: 2.778

7.  Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy.

Authors:  R L Spicer; A P Rocchini; D C Crowley; J Vasiliades; A Rosenthal
Journal:  Circulation       Date:  1983-02       Impact factor: 29.690

8.  Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study.

Authors:  R Lang; H O Klein; E Di Segni; J Gefen; P Sareli; C Libhaber; D David; E Weiss; J Guerrero; E Kaplinsky
Journal:  Am Heart J       Date:  1983-05       Impact factor: 4.749

9.  The influence of verapamil on serum digoxin concentration.

Authors:  H O Klein; R Lang; E Weiss; E Di Segni; C Libhaber; J Guerrero; E Kaplinsky
Journal:  Circulation       Date:  1982-05       Impact factor: 29.690

10.  Cardiac arrhythmias in hypertrophic cardiomyopathy.

Authors:  I Bjarnason; T Hardarson; S Jonsson
Journal:  Br Heart J       Date:  1982-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.